Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the standoff at Standing Rock or news about the movements fighting for peace, racial and economic justice, immigrant rights and LGBTQ equality. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How is this possible? Only with your support. If every visitor to this site in December gave just $10 we could cover our basic operating costs for 2017. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else in 2017.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


As the Bush Administration Sets Aside Half of the Military's Supply of Anthrax Vaccine for Civilian Use, a Look at the Anthrax Vaccine and Bioport, the Company That Makes It

StoryJuly 22, 2002
Watch iconWatch Full Show

The Bush administration is set to resume using the controversial anthrax vaccine on soldiers as well as civilians. The Pentagon announced in May the military will resume anthrax vaccinations for "at risk" troops. Soldiers receiving the vaccine will not be disclosed "for security reasons." A month later, the Bush administration announced it will set aside about half of the military’s supply of anthrax vaccine for civilian use in case of a biological attack.

But it is still not clear whether the anthrax vaccine is safe or even effective.

In the last four years, a number of published studies have linked anthrax vaccination to the development of Gulf War Syndrome, among them a study in the British medical journal the Lancet. Hundreds of soldiers have refused the shots, after evidence emerged that the vaccinations are connected to a variety of illnesses.

But then the Bush administration went on the offensive. The Pentagon funded an Institute of Medicine study which concluded in March the anthrax vaccine is safe and effective against all anthrax strains and routes of infection. Its conclusions were based on unpublished research–also funded by the Pentagon.

The story doesn’t stop there. Bioport, the nation’s sole anthrax vaccine lab has repeatedly failed FDA inspections which found among other things, contamination. Admiral Crowe, former chair of the Joint Chiefs of Staff, is one the founding partners of Bioport.

The FDA cleared BioPort’s manufacturing plant to begin producing the vaccine again last January–months after the letters containing anthrax were sent to Congress and news organizations. Bioport was also allowed to distribute the 500,000 doses of the vaccine already in stock. The vaccine was offered to some postal workers and others who were exposed. But most refused to take it.

Today we are joined by three people to talk about Bioport and the anthrax vaccine. Democracy Now! called the Centers for Disease Control and Prevention and the Pentagon, but they said no representative was available to come on the program today.


  • Thomas Dennie Williams, reporter for the Hartford Courant who covers anthrax.
  • Kim Brennen-Root, spokesperson for Bioport Corp.
  • Meryl Nass, anthrax expert, physician and writer. Nass has more knowledge about the adverse reactions to anthrax than probably anyone in the world. She is the expert witness in several lawsuits on the anthrax vaccine. Nass identified the 1979 anthrax outbreak in Zimbabwe as bio-terrorism. It was the largest outbreak of human anthrax in history.

Related links:

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.

Make a donation